Citation Impact
Citing Papers
Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica
2008 StandoutScience
Mutations in NALP12 cause hereditary periodic fever syndromes
2008
Chagas disease
2010 Standout
Nucleotide Oligomerization Binding Domain-Like Receptor Signaling Enhances Dendritic Cell-Mediated Cross-Priming In Vivo
2009 StandoutNobel
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
NLRP3/Cryopyrin Is Necessary for Interleukin-1β (IL-1β) Release in Response to Hyaluronan, an Endogenous Trigger of Inflammation in Response to Injury
2009
The N-terminal Domain of Drosophila Gram-negative Binding Protein 3 (GNBP3) Defines a Novel Family of Fungal Pattern Recognition Receptors
2009 StandoutNobel
Genetics of scleroderma: implications for personalized medicine?
2013
NALPs: a novel protein family involved in inflammation
2003
Immunogenetics of systemic sclerosis: Defining heritability, functional variants and shared-autoimmunity pathways
2015
Genetics and Genomic Studies in Scleroderma (Systemic Sclerosis)
2008
Fondaparinux Compared with Enoxaparin for the Prevention of Venous Thromboembolism after Hip-Fracture Surgery
2001
Gout-associated uric acid crystals activate the NALP3 inflammasome
2006 StandoutNature
AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC
2009 StandoutNature
Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada
2006
NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis
2011 Standout
NODs: intracellular proteins involved in inflammation and apoptosis
2003
Autoinflammatory Disease Reloaded: A Clinical Perspective
2010 Standout
Unravelling the pathogenesis of inflammatory bowel disease
2007 StandoutNature
The NLRP3 inflammasome: molecular activation and regulation to therapeutics
2019 Standout
Cryopyrin activates the inflammasome in response to toxins and ATP
2006 StandoutNature
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
2012 StandoutNature
Physiology and Neurobiology of Stress and Adaptation: Central Role of the Brain
2007 Standout
Shared Principles in NF-κB Signaling
2008 Standout
Juvenile idiopathic arthritis
2007 Standout
Recognition of microorganisms and activation of the immune response
2007 StandoutNature
Critical Role for NALP3/CIAS1/Cryopyrin in Innate and Adaptive Immunity through Its Regulation of Caspase-1
2006
Inflammatory caspases and inflammasomes: master switches of inflammation
2006
Genetic factors and systemic sclerosis
2016
Pattern Recognition Receptors and Inflammation
2010 Standout
Systemic sclerosis
2017 Standout
Perioperative Bridging Therapy With Unfractionated Heparin or Low-Molecular-Weight Heparin in Patients With Mechanical Prosthetic Heart Valves on Long-Term Oral Anticoagulants (from the REGIMEN Registry)
2008
ATP-sensitive potassium channels mediate survival during infection in mammals and insects
2007 StandoutNobel
Familial autoinflammatory diseases: genetics, pathogenesis and treatment
2005
Inflammatory bowel disease: cause and immunobiology
2007 Standout
Scleroderma
2009 Standout
Hypoxia and Hypoxia Signaling in Tissue Repair and Fibrosis
2012
Unified Polymerization Mechanism for the Assembly of ASC-Dependent Inflammasomes
2014 Standout
Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities
2011
Medical therapy of pericardial diseases
2010
Intracellular Toll-like Receptors
2010 StandoutNobel
Musculoskeletal Manifestations of Systemic Sclerosis
2015
Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study
2008 Standout
NALP Inflammasomes: a central role in innate immunity
2007
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials
2001
Predictors of interstitial lung disease in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohort
2010
Hereditary lysozyme amyloidosis – phenotypic heterogeneity and the role of solid organ transplantation
2011
Inflammasome-Mediated Disease Animal Models Reveal Roles for Innate but Not Adaptive Immunity
2009
Toll-like receptor signalling
2004 Standout
Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist
2004
Type 2 diabetes
2017 Standout
Myocarditis
2011 Standout
Genetics of systemic sclerosis
2015
Systems Level Analysis of Systemic Sclerosis Shows a Network of Immune and Profibrotic Pathways Connected with Genetic Polymorphisms
2015
The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement: the EXPRESS study
2003
Systemic amyloidosis
2015 Standout
Functional screening of five PYPAF family members identifies PYPAF5 as a novel regulator of NF‐κB and caspase‐1
2002
Genetics, Epigenetics, and Genomics of Systemic Sclerosis
2015
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
2004 Standout
Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf
2004 StandoutNature
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
2012 Standout
Non-canonical inflammasome activation targets caspase-11
2011 StandoutNature
Activation-Induced Cytidine Deaminase Expression in CD4+ T Cells is Associated with a Unique IL-10-Producing Subset that Increases with Age
2011 StandoutNobel
Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty
2008 Standout
Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectives
2015
Identification of Bacterial Muramyl Dipeptide as Activator of the NALP3/Cryopyrin Inflammasome
2004
The Inflammasomes
2010 Standout
Mechanisms and Functions of Inflammasomes
2014 Standout
Spectrum of clinical features in Muckle‐Wells syndrome and response to anakinra
2004
NLRP3 inflammasome inhibition is disrupted in a group of auto-inflammatory disease CAPS mutations
2016
Recognition of Hyaluronan Released in Sterile Injury Involves a Unique Receptor Complex Dependent on Toll-like Receptor 4, CD44, and MD-2
2007 StandoutNobel
Systemic sclerosis
2015
Inferences, questions and possibilities in Toll-like receptor signalling
2004 StandoutNatureNobel
Molecular Mechanisms of Amyloidosis
2003 Standout
Pathogen Recognition and Innate Immunity
2006 Standout
Inflammasomes in health and disease
2012 StandoutNature
Cryopyrin-associated periodic syndromes and autoinflammation
2007
Temporal Trends in Prevention of Venous Thromboembolism Following Primary Total Hip or Knee Arthroplasty 1996–2001
2003
Genetic clues to understanding periodic fevers, and possible therapies
2002
Recent Advances in the Genetics of Autoimmune Disease
2008
Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease
2019 Standout
Tyrosine Phosphatase PTPN22: Multifunctional Regulator of Immune Signaling, Development, and Disease
2013
Nods, Nalps and Naip: intracellular regulators of bacterial-induced inflammation
2003
Interactions Between the Microbiota and the Immune System
2012 StandoutScience
Loss of the Protein Tyrosine Phosphatase PTPN22 Reduces Mannan-Induced Autoimmune Arthritis in SKG Mice
2016 StandoutNobel
Role of Glycated Proteins in the Diagnosis and Management of Diabetes: Research Gaps and Future Directions
2016
Role of IL-13 in systemic sclerosis
2011
Inflammation and autoimmunity caused by a SHP1 mutation depend on IL-1, MyD88, and a microbial trigger
2008 StandoutNobel
Chronic Fatigue Syndrome and High Allostatic Load
2006
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Effect of Macitentan on the Development of New Ischemic Digital Ulcers in Patients With Systemic Sclerosis
2016
The Epidemiology of Venous Thromboembolism
2003 Standout
NOD-LRR PROTEINS: Role in Host-Microbial Interactions and Inflammatory Disease
2005
IL-Converting Enzyme/Caspase-1 Inhibitor VX-765 Blocks the Hypersensitive Response to an Inflammatory Stimulus in Monocytes from Familial Cold Autoinflammatory Syndrome Patients
2005
Nod2 Deficiency Augments Th17 Responses and Exacerbates Autoimmune Arthritis
2018 StandoutNobel
Cutting Edge: Recent Immune Status Determines the Source of Antigens That Drive Homeostatic T Cell Expansion
2005
Mechanisms of pathogenesis in Chagas disease
2006
Works of B. Granel being referenced
<i>CIAS1</i> Mutation in a Patient with Overlap between Muckle-Wells and Chronic Infantile Neurological Cutaneous and Articular Syndromes
2003
Association between the IRF5 rs2004640 functional polymorphism and systemic sclerosis: A new perspective for pulmonary fibrosis
2008
Cannabis Arteritis Revisited
2001
Pretreatment with corticosteroids attenuates the efficacy of colchicine in preventing recurrent pericarditis: a multi-centre all-case analysis
2005
New Mutations of CIAS1 That Are Responsible for Muckle-Wells Syndrome and Familial Cold Urticaria: A Novel Mutation Underlies Both Syndromes
2002
Generalized calcinosis in systemic sclerosis
2013
Association of hypoxia‐inducible factor 1A (HIF1A) gene polymorphisms with systemic sclerosis in a French European Caucasian population
2009
Genetic susceptibility to systemic sclerosis
2008
STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis
2009
Comparing HLA Shared Epitopes in French Caucasian Patients with Scleroderma
2012
The PTPN22 620W allele confers susceptibility to systemic sclerosis: Findings of a large case–control study of European Caucasians and a meta‐analysis
2008
Evaluation of interleukin 13 polymorphisms in systemic sclerosis
2006
Efficacy of sildenafil on ischaemic digital ulcer healing in systemic sclerosis: the placebo-controlled SEDUCE study
2015
A family with gastrointestinal amyloidosis associated with variant lysozyme
2002
Lysozyme Amyloidosis
2006
Le peptide natriurétique de type b
2004
Interference of dapsone in HbA1c monitoring of a diabetic patient with polychondritis.
2002
IL13RA2 gene polymorphisms are associated with systemic sclerosis.
2006
[Diagnostic approach to hypereosinophilia].
1998